OTC Obesity - Australia

Date: June 22, 2010
Pages: 33
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O05E151185BEN
Leaflet:

Download PDF Leaflet

OTC obesity posted growth of 4% in current value during 2009, with sales reaching A$31 million. Rising obesity and overweight levels in Australia have received much attention from government agencies and in the media, with confirmation by the latest National Health Survey (2007-08) that one quarter of the country’s adults are obese and an additional 37% of the adult population are overweight.

Euromonitor International's OTC Obesity Products in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage:

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Consumer Health Maintained Steady Growth
H1n1 Influenza Rapidly Developed During the 2009 Winter
Sanofi-aventis Healthcare Pty Ltd Gained Leadership in Consumer Health
Grocery Retailers and Direct Selling Gained Distribution Share
Consumer Health Sales Growth Expected To Hold Steady Over the Forecast Period
Key Trends and Developments
Consumer Health Spending Unabated by Economic Downturn
Fear of H1n1 Influenza Pandemic Facilitated Sales
Grocery Retailers Channel Intensifies Competition for Retail Distribution Share
National Preventative Health Strategy
Ageing Profile of Australian Consumers
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Penetration of Private Label by Sector 2004-2009
  Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 1 OTC Healthcare Switches 2008-2009
Definitions
Sector and Subsector Definitions
  Summary 2 Research Sources
Blackmores Ltd
Strategic Direction
Key Facts
  Summary 3 Blackmores Ltd: Key Facts
  Summary 4 Blackmores Ltd: Operational Indicators 2007-2009
Company Background
Production
  Summary 5 Blackmores Ltd: Production Statistics 2009
Competitive Positioning
  Summary 6 Blackmores Ltd: Competitive Position 2009
Ego Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
  Summary 7 Ego Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
  Summary 8 Ego Pharmaceuticals Pty Ltd: Production Statistics 2009
Competitive Positioning
  Summary 9 Ego Pharmaceuticals Pty Ltd: Competitive Position 2009
Herron Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
  Summary 10 Herron Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
  Summary 11 Herron Pharmaceuticals Pty Ltd: Production Statistics 2009
Competitive Positioning
  Summary 12 Herron Pharmaceuticals Pty Ltd: Competitive Position 2009
Inova Pharmaceuticals (australia) Pty Ltd
Strategic Direction
Key Facts
  Summary 13 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
Company Background
Production
  Summary 14 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2009
Competitive Positioning
  Summary 15 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2009
Swisse Natural Health Products Pty Ltd
Strategic Direction
Key Facts
  Summary 16 Swisse Natural Health Products Pty Ltd: Key Facts
Company Background
Production
  Summary 17 Swisse Natural Health Products Pty Ltd: Production Statistics 2008
Competitive Positioning
  Summary 18 Swisse Natural Health Products Pty Ltd: Competitive Position 2009
Trends
Category Data
  Table 12 Sales of OTC Obesity: Value 2004-2009
  Table 13 Sales of OTC Obesity: % Value Growth 2004-2009
  Table 14 OTC Obesity Company Shares by Value 2005-2009
  Table 15 OTC Obesity Brand Shares by Value 2006-2009
  Table 16 Forecast Sales of OTC Obesity: Value 2009-2014
  Table 17 Forecast Sales of OTC Obesity: % Value Growth 2009-2014
Skip to top


OTC Obesity - Austria US$ 990.00 Apr, 2010 · 31 pages
OTC Obesity - Denmark US$ 990.00 Apr, 2010 · 29 pages
OTC Obesity - France US$ 990.00 Apr, 2010 · 49 pages
OTC Obesity - Greece US$ 990.00 Mar, 2010 · 33 pages
OTC Obesity - Netherlands US$ 990.00 Jun, 2010 · 32 pages

Ask Your Question

OTC Obesity - Australia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: